CD274 and neoplasm: Finally, we evaluated the TLS Score repartition according to PD-L1 categories characterized by different PD-L1 positivity cut-off (>1% or >50% positivity) on the surface of the tumor cells (Figure 6H) or immune cells (Figure 6I).